A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and tolerability profile of tramadol
hydrochloride (HCl) given as oral doses every 6 hours, within the range of dosages supported
by currently available toxicology and clinical data (200 mg to 600 mg per day).
Phase:
Phase 1
Details
Lead Sponsor:
Janssen Scientific Affairs, LLC
Collaborators:
Bausch Health Americas, Inc. Cipher Pharmaceuticals Inc. Valeant Pharmaceuticals International, Inc.